AC Forum header    
December 2012  Newsletter

                                                                                  
A publication of the Anticoagulation Forum
 

12th National Conference on Anticoagulant Therapy 

 

  

May 9-11, 2013

 

 

JW Marriott

 Desert Ridge Resort

Phoenix, Arizona

 Registration Now Open!

 
 
Our Mission

 

The Anticoagulation Forum is a multidisciplinary nonprofit organization of healthcare professionals that will improve the quality of care for patients taking antithrombotic medications.
 
 
Board of Directors

 

Jack Ansell, MD
Mark Crowther, MD
David Garcia, MD
Alan Jacobson, MD
Scott Kaatz, DO
Stephan Moll, MD
Edith Nutescu, PharmD
Lynn Oertel, MS
Terri Schnurr, RN
Daniel Witt, PharmD
Ann Wittkowsky, PharmD

 

 

Contact Us

 

Executive Director
Anticoagulation Forum

 

 

 

 

 

This newsletter is provided for informational purposes only and is not intended to provide specific medical advice, diagnosis, or treatment. You should always seek advice from a physician or other qualified health care provider for your individual medical needs. The AC Forum does not endorse or recommend any commercial products.

Not A Member Yet?

 

Header  

To Join the AC Forum

or learn more about us please

Visit our website

In This Issue
Centers of Excellence Web Site Launched
January Webinar
Cranberry & Warfarin OK
Early Bird Conference Registration Deadline
Excellence logo

 

 Centers of Excellence Web Site Launched

 

                 www.excellence.acforum.org   

 

The AC Forum is pleased to announce the launch of the Anticoagulation Centers of Excellence program. This program has been created to help healthcare professionals provide the highest level of care, and achieve the best possible outcomes for their patients on antithrombotic medications. 

 

There are three essential components of the Centers of Excellence program; an assessment tool to determine if your anticoagulation service is operating at the highest level; a comprehensive resource center that provides the guidelines and tools to improve towards excellence; and "Examples of Excellence", where practices are encouraged to share examples of innovative and successful solutions in patient care or service management. 

 

Upon successful completion of the assessment survey, clinics will receive recognition as an "Anticoagulation Center of Excellence", valid for two years.   

 

To learn more about this exciting new program, please register for the January Lunch & Learn webinar being offered by the AC Forum. To register, follow instructions below.

January Webinar :
An Introduction to the New Anticoagulation Centers of Excellence Program  
January 9, 2013 1:00 PM EST
  
The Lunch and Learn Webinar for January will take place on Wednesday, January 9, 2013 from 1:00 PM-2:00 PM, EST. There will be an introduction and extended Q & A period for members to learn about the new Anticoagulation Centers of Excellence program. This exciting program offers the opportunity  to conduct a self-assessment as well as benefit from a vast resource center for improving patient care. This webinar will include panelists who served as committee chairs in the research and development for this site. Learn how your service can achieve recognition as an Anticoagulation Center of Excellence.
 
Space is limited.
Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/729285034  
  
 Cranberry & Warfarin OK Together
  
By Edith A. Nutescu, Pharm.D., FCCP, Clinical Professor,
Ittiporn Chuatrisorn, MS, Pharm.D. Candidate Department of Pharmacy Practice,The University of Illinois at Chicago College of Pharmacy Antithrombosis Clinic University of Illinois Hospital & Health Sciences System
  

In a recent update of the Coumadin (Warfarin) prescribing information and the corresponding Medication Guide1, the caution statement to avoid cranberry juice or cranberry products while patients are taking warfarin has been removed. 

 

The Medication Guide was updated because, while several case reports 2-3 reported a potential interaction between cranberry products and warfarin, more recent clinical trials that studied patients before and after consuming cranberry juice found no clinically significant interaction.Two of the most recent studies have found similar results showing that consumption of 8-16 ounces of cranberry juice daily for up to 1-2 weeks was safe.4-5 Neither study evaluated any cranberry products other than cranberry juice; however, the revised labeling 1 has removed caution against cranberry juice and other cranberry products allowing warfarin patients to also consume alternate cranberry products.

 

The effect of large amounts of cranberry products (~0.5-2 liters of juice, or 30-120g of sauce, or 1,00mg capsules per day) for long periods of time on warfarin variability still remains to be elucidated. Thus thorough patient education is key in order to facilitate the safe use of cranberry products in patients on warfarin. Highlighting the importance of type, appropriate amount, and duration of cranberry product consumption is especially important until further data becomes available on consumption of larger product amounts for longer time durations. See below for a Patient's Guide to Cranberry Products and Coumadin (Warfarin) that you might find helpful in education of your patients.

 

 

  1. Bristol-Myers Squibb Company. Medication Guide for Coumadin Tablets and Coumadin for Injection [Package Insert]. Princeton, NJ: Bristol-Myers Squibb Company. 2011
  2. Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinaemia and bleeding. American Journal of Therapeutics 2006; 13: 283-284.
  3. Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clinical Therapeutics. 2007; 29(8):1730
  4. Ansell, Jack. (2009). The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. Journal of Clinical Pharmacology, 49:824-830.
  5. Mellen, Chadwick K. (2010). Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. British Journal of Clinical Pharmacology, DOI:10.1111/j.1365-2125.2010.03674.
  6. Bristol-Myers Squibb Company. Medication Guide for Coumadin Tablets and Coumadin for Injection [Package Insert]. Princeton, NJ: Bristol-Myers Squibb Company. 2009

 

A Patient's Guide to Cranberry Products and Coumadin (Warfarin)

 

Coumadin (Warfarin) is a commonly prescribed "blood thinner." Its therapeutic effect varies in any given individual, and even minor variations can lead to problems. Therefore, your healthcare providers may advise against taking certain foods and herbal supplements. Are cranberry products safe to consume while also taking warfarin?

 

Clinical trials that evaluated the effects of cranberry consumption on warfarin therapy have not found a clinically significant interaction. According to these data, consumption of cranberry products appears to be safe in patients taking warfarin. The Coumadin (Warfarin) prescribing information and medication guide were recently updated, and no longer list cranberries as a potentially interacting food.  

 

Recommendations

  • Moderate intake of cranberries such as drinking cranberry juice, about 1 -2 glasses per day is safe in patients taking warfarin.
  • The effect of drinking or eating extremely large amounts of cranberry products (~0.5-2 liters of juice, or 30-120g of sauce, or 1,00mg capsules per day) for long periods of time on warfarin variability requires further investigation.
  • Talk to your healthcare provider before large increases in cranberry products in your diet for extended periods of time.
  • Check your skin closely for easy bruising or red spots. This may be a sign of bleeding. If you notice any bleeding, notify your doctor right away.
  
   Early Bird Conference
   Registration  Deadline       
       January 5, 2013
desert ridge

12th National Conference on Anticoagulant Therapy
 May 9-11, 2013

JW Marriott Desert Ridge Phoenix, AZ

 

   
Visit our newly expanded conference website at acforum2013.org 
for complete conference details including the agenda, speakers, registration fees, and hotel information.